×

Special Offer! Limited-Time Offer! Get 25% Off on All Certification Exams – Prepare & Pass with Confidence! Use Code:  DC25OFF  

Free Test Prep PCAT Exam Questions

Try our Free Demo Practice Tests for Comprehensive PCAT Exam Preparation

  • Test Prep PCAT Exam Questions
  • Provided By: Test Prep
  • Exam: Pharmacy College Admission Test
  • Certification: Test Prep Certifications
  • Total Questions: 285
  • Updated On: Apr 04, 2025
  • Rated: 4.9 |
  • Online Users: 570
Page No. 1 of 57
Add To Cart
  • Question 1
    • If ƒ(x) = 3x and g(x) = 2x2, what is g(ƒ(−2))?

      Answer: D
  • Question 2
    • ln e7 = 1 − x, what is x?

      Answer: C
  • Question 3
    • Which of the following organisms has a circulatory system in which blood circulates in an internal cavity called a hemocoel?

      Answer: C
  • Question 4
    • For most Americans, the words “Alzheimer’s disease” (AD) – often mispronounced purposefully or accidentally
      as “old timers’ disease” – signify devastating memory loss and stigma. The information about AD – often
      learned solely through the media – may lead individuals to believe that AD is inevitable (it isn’t), and possibly
      think that all AD patients receive poor care (there are many remarkably good AD units). Many individuals may
      envision a future burdened with more dementia patients and fewer societal resources to help support them (a
      real possibility). In general, pharmacists are well aware of what AD is and isn’t. AD is complex and relentlessly
      progressive; it affects patients, loved ones, and caregivers adversely. Pharmacists can provide pertinent
      information about AD’s myths, realities, and available symptomatic treatments. AD’s harbinger is language
      difficulties, which include aphasia (language disturbance), apraxia (inability to carry out motor functions), and
      agnosia (failure to recognize or identify objects). Consequently, those with AD will often create new words for
      items. They may call a pencil a “list writer,” or a key a “door turner.” Clinicians stage AD as mild, moderate, or
      severe depending on the patient’s cognitive and memory impairment, communication problems, personality
      changes, behavior, and loss of control of bodily functions. People often dismiss mild AD as normal cognitive
      decline or senility – in other words, “normal” aging. For this reason, most people don’t seek treatment and are
      diagnosed in the late-mild to early-moderate stage. In the severe stage, difficulty swallowing elevates the risk of
      aspiration pneumonia, which often marks the beginning of the downward spiral that ultimately ends with death;
      AD has no cure. A handful of pharmacologic treatments – acetylcholinesterase inhibitors and N-methyl-Daspartate antagonists – alter the decline trajectory. These treatments slow disease progression, enhance
      cognitive function, delay cognitive decline, and decrease disruptive behaviors. Not all patients respond to these
      medications, but experts generally believe that those who do will show mild to moderate improvements for 6
      months to a year. Although the drugs’ effects are short-lived, they improve patients’ quality of life and briefly
      enable independence. Determining when medications stop providing a therapeutic benefit and should be
      discontinued is challenging. Clinicians use various methods to monitor decline, including mental status tools,
      patient self-report, and loved ones’ observations. Most clinicians continue drug treatment if the patient seems to
      tolerate the medication well, can afford it, and if there seems to be a benefit. With disease progression, specific
      behavioral symptoms including depression, agitation, hallucinations, and sleep disturbances become concerns.
      Antianxiety drugs, antipsychotics, and antidepressants are sometimes used to alleviate symptoms, but effective
      behavioral strategies are much preferred.
      The author’s attitude toward Alzheimer’s disease is best summarized by which of the following?

      Answer: B
  • Question 5
    • Since 1997, the American Heart Association (AHA) has attempted to increase awareness about cardiovascular
      disease (CVD) among women. Fortunately, great progress has been made to educate individuals about CVD
      and its consequences. According to the AHA’s 2011 Guidelines for Prevention of Cardiovascular Disease in
      Women, the misconception that CVD is a “man’s disease” has been somewhat disproved, as awareness
      among the general public increased from 30% in 1997 to 54% in 2009. Unfortunately, CVD continues to be the
      leading cause of death in the United States for both men and women. Since 1984, the number of deaths related
      to CVD in women exceeded those in men. In the United States, CVD death rates among women aged 35 to 54
      years appear to be increasing by 1% annually, which is most likely attributable to the escalating obesity
      epidemic. According to the AHA, even though CVD is the number 1 cause of death among women, only 13% of
      women perceive CVD as a health threat. CVD is responsible for more deaths among women than the next 3
      leading causes of death combined, including all forms of cancer. Due to the ongoing prevalence of CVD,
      increasing awareness and understanding of CVD, especially among the female population, is still a top priority
      for many health care professionals. As one of the most accessible health care professionals, pharmacists are in
      a pivotal position to educate and inform their patients of the risks associated with CVD, possible drug therapies,
      and preventive measures. The AHA has set a goal for 2020 to improve cardiovascular health in all Americans
      by 20%, while reducing deaths from CVD and stroke by 20%. According to the American Heart Association, in
      the United States a woman dies of some form of CVD every minute and more than 1 in 3 females have some
      form of CVD. Studies have demonstrated that gender differences may play an important role in the diagnosis,
      treatment, and prevention of CVD. Unfortunately, many women may not always recognize the warning signs
      and symptoms of a heart attack because they sometimes appear more subtle when compared with those
      typically experienced by men. Results from a study of 515 women who had heart attacks report that 43% did
      not experience any type of chest pain or pressure during the heart attack. Although the classic symptoms
      include chest pain, tingling in the left arm, sweating, and shortness of breath, women may also experience
      some “atypical” symptoms, such as extreme fatigue, nausea, dizziness, indigestion, vomiting, and pain in the
      neck or back. By learning and recognizing the warning signs, women can take a proactive approach to their
      cardiovascular health and get treatment earlier to prevent further complications.
      Throughout the passage, it is implied that which of the following will lead to fewer deaths resulting from CVD?

      Answer: B
PAGE: 1 - 57
Add To Cart

© Copyrights Dumpscity 2025. All Rights Reserved

We use cookies to ensure your best experience. So we hope you are happy to receive all cookies on the Dumpscity.